EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Modern Management of Asymptomatic Carotid Stenosis: A Meta‐Analysis of CREST ‐2, SPACE ‐2, and ECST ‐2

Aasim Ali, Waqar Ahmed Cheema iD, Fiza Nisar, Muhammad Shamoon, Sameen Sarfaraz, Ahmad Butt, Muhammad Abdullah Ali, Armaghana Abdullah, Muhammad Asad Shabbir, Muhammad Talha, Hammad Azam, Aimen Anwaar Pannun und 3 weitere

Annals of Clinical and Translational Neurology · 13.07.2026

DOI: 10.1002/acn3.70479 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 13.07.2026. Verfasst von Aasim Ali und 14 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Department, Allied Hospital Faisalabad, Faisalabad, Pakistan. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Recent randomized trials (CREST‐2, SPACE‐2, and ECST‐2) have compared carotid revascularization (carotid endarterectomy [CEA] or carotid artery stenting [CAS]) plus contemporary medical therapy (CMT) versus CMT alone in asymptomatic carotid stenosis. ECST‐2 included both asymptomatic and low‐risk symptomatic patients, introducing clinical heterogeneity. Individual trials reported low event rates and limited statistical power.

Objective

To evaluate whether carotid revascularization reduces long‐term ipsilateral stroke (> 30 days) compared with CMT alone and to assess periprocedural complications.

Methods

Phase 3/4 randomized controlled trials published after 2020 were included. The primary outcome was long‐term ipsilateral stroke excluding periprocedural events. Periprocedural complications (30‐day stroke, myocardial infarction, or death) were analyzed separately. Random‐effects models were used. Subgroup analyses by modality (CEA vs. CAS) included CREST‐2 and SPACE‐2. Sensitivity analyses excluding ECST‐2 and using split‐control methodology for SPACE‐2 were performed.

Results

Three trials (5 arms; 3438 patients) were included. Median follow‐up was 4.0 years in CREST‐2, 5.0 years in SPACE‐2, and 2.0 years in ECST‐2. In the primary pooled analysis including ECST‐2, revascularization showed a nonsignificant reduction in long‐term ipsilateral stroke (RR 0.51; 95% CI 0.21–1.29; p = 0.16; I 2 = 70%) and a borderline increase in periprocedural complications (RR 2.78; p = 0.06). Sensitivity analyses excluding ECST‐2 suggested reduced long‐term ipsilateral stroke with revascularization (RR 0.35; 95% CI 0.21–0.58; p < 0.0001; I 2 = 0%; ARR 2.74%; NNT = 37) but increased periprocedural complications (RR 4.54; p = 0.004; I 2 = 0%; ARI 1.45%; NNH = 69). Subgroup analyses suggested a possible benefit with CAS, whereas CEA showed a nonsignificant trend; however, subgroup analyses were underpowered. Split‐control sensitivity analyses for SPACE‐2 yielded directionally similar findings with wider confidence intervals.

Conclusion

The primary pooled analysis was inconclusive and demonstrated substantial heterogeneity. Sensitivity analyses restricted to purely asymptomatic populations suggested that carotid revascularization may reduce long‐term ipsilateral stroke but increase periprocedural complications. Contemporary medical therapy remains the foundation of management for asymptomatic carotid stenosis, while revascularization should be reserved for carefully selected patients after individualized risk assessment and shared decision‐making.

Schlagwörter

Stichwörter der Autor:innen

asymptomatic carotid stenosiscarotid revascularizationcontemporary medical therapymeta‐analysisrandomized controlled trials

Autor:innen und Institutionen

  • Neurology Department, Allied Hospital Faisalabad, Faisalabad, Pakistan.
  • Internal Medicine Department, Allied Hospital Faisalabad, Faisalabad, Pakistan.
  • Neurology Department, Dhankuta District Hospital, Dhankuta, Nepal.

ORCID-Profile: Waqar Ahmed Cheema, Mukesh Sharma

Zitieren

APA

Ali, A., Cheema, W. A., Nisar, F., Shamoon, M., Sarfaraz, S., Butt, A., Ali, M. A., Abdullah, A., Shabbir, M. A., Talha, M., Azam, H., Pannun, A. A., Saleem, U., Tanveer, A., & Sharma, M. (2026). Modern Management of Asymptomatic Carotid Stenosis: A Meta‐Analysis of CREST ‐2, SPACE ‐2, and ECST ‐2. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.70479

Vancouver

Ali A, Cheema WA, Nisar F, Shamoon M, Sarfaraz S, Butt A, et al. Modern Management of Asymptomatic Carotid Stenosis: A Meta‐Analysis of CREST ‐2, SPACE ‐2, and ECST ‐2. Annals of Clinical and Translational Neurology. 2026. doi:10.1002/acn3.70479

BibTeX
@article{Ali2026,
  author = {Ali, Aasim and Cheema, Waqar Ahmed and Nisar, Fiza and Shamoon, Muhammad and Sarfaraz, Sameen and Butt, Ahmad and Ali, Muhammad Abdullah and Abdullah, Armaghana and Shabbir, Muhammad Asad and Talha, Muhammad and Azam, Hammad and Pannun, Aimen Anwaar and Saleem, Usama and Tanveer, Anousha and Sharma, Mukesh},
  title = {Modern Management of Asymptomatic Carotid Stenosis: A Meta‐Analysis of CREST ‐2, SPACE ‐2, and ECST ‐2},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2026},
  doi = {10.1002/acn3.70479}
}
Kostenlos starten →